# Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery

> **NCT01144611** · PHASE3 · COMPLETED · sponsor: **Alloksys Life Sciences B.V.** · enrollment: 53 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** bIAP bolus and 8h infusion
- **DRUG:** placebo bolus and 8h infusion

## Key facts

- **NCT ID:** NCT01144611
- **Lead sponsor:** Alloksys Life Sciences B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144611, "Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01144611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*